HR
Hollings Renton (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AnaptysBio, Inc. (ANAB). The largest single filing was $249K of ANAB (5,000 sh × $49.87, as filed), executed Oct 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$249K
shares × price, as filed
Last traded
Oct 1
Filed Oct 2
Median ADV $28.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ANABRecent filings
ANABSALE
AnaptysBio, Inc.
View filing →
$249K5,000 sh × $49.87
Exec Oct 1
Filed Oct 2 · 5:47 PM ET ANABSALE AnaptysBio, Inc. View filing → $140K
7,121 sh × $19.70
Exec Aug 8 2025
Filed Aug 12 2025 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $493K
20,925 sh across 2 lots
Exec Jul 2 2025
Filed Jul 3 2025 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $250K
10,000 sh × $25.00
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET